IP Library Granted Patent US 9,119,578
Granted Patent B2
US 9,119,578 · App. 13/456,505 · Granted Sep 1, 2015

Plasma or serum production and removal of fluids under reduced pressure

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,119,578
App. No.
13/456,505
Granted
Sep 1, 2015
Kind
B2
Abstract

In some embodiments, the present invention generally relates to the separation of blood within a device to form plasma or serum. In some embodiments, the present invention generally relates to the removal of fluids, such as blood, contained within a device. For example, a device may be applied to the skin of a subject to receive blood from the subject and pass the blood through a separation membrane, which separates the blood into plasma and a portion concentrated in blood cells. As another example, blood or plasma may be allowed to clot within the device and serum (the unclotted portion of the blood) may be withdrawn from the device. The device may contain, in some cases, a vacuum source such as a pre-packaged vacuum to facilitate receiving of blood and/or passage of the blood through the separation membrane to produce plasma or serum.

Claims (21)

1. A device for receiving bodily fluid from a subject and processing the bodily fluid to form plasma or serum, the device comprising:

an opening for introduction of a bodily fluid from the subject into the device;

a separation membrane in fluid communication with the opening on a first side of the membrane, the separation membrane sized such that the bodily fluid passing therethrough is separated to form plasma or serum;

a vacuum chamber having a pressure less than ambient pressure before the device is applied to the skin of the subject;

a seal that can be manipulated to control a fluid communication pathway between the vacuum chamber and a second side of the separation membrane; and

a flow activator comprising one or more microneedles positioned to cause release of bodily fluid from the subject.

2. The device of claim 1 , wherein the separation membrane comprises a polysulfone.

3. The device of claim 1 , wherein the separation membrane comprises a polyethersulfone.

4. The device of claim 1 , wherein the separation membrane comprises a nitrocellulose.

5. The device of claim 1 , wherein the separation membrane has an average pore diameter of less than about 20 micrometers.

6. The device of claim 1 , wherein the separation membrane has an average pore diameter of less than about 8 micrometers.

7. The device of claim 1 , wherein the separation membrane has an average pore diameter of less than about 4 micrometers.

8. The device of claim 1 , wherein the opening is positioned within an applicator region positioned to collect bodily fluid from the skin of the subject.

9. The device of claim 1 , wherein the vacuum chamber has a pressure, prior to introduction of a bodily fluid from the subject into the device, that is lower than about 100 mmHg below ambient pressure.

10. The device of claim 1 , further comprising a storage chamber in fluid communication with the second side of the separation membrane.

11. The device of claim 10 , wherein the storage chamber contains an anticoagulant.

12. The device of claim 1 , wherein the separation membrane has an area less than 5 square centimeters.

13. The device of claim 1 , wherein the separation membrane has an area less than 1 square centimeter.

14. The device of claim 1 , wherein the separation membrane has an area less than 0.5 square centimeters.

15. The device of claim 1 , wherein the separation membrane contains an anticoagulant.

16. The device of claim 1 , wherein the fluid communication pathway contains an anticoagulant.

Assignments (6)
CHANGE OF NAME Recorded Sep 17, 2021
From: SEVENTH SENSE BIOSYSTEMS, INC.
To: YOURBIO HEALTH, INC.
Reel/Frame 057538/0050 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2018
From: COMERICA BANK
To: SEVENTH SENSE BIOSYSTEMS, INC.
Reel/Frame 047902/0113 →
SECURITY INTEREST Recorded Feb 26, 2018
From: SEVENTH SENSE BIOSYSTEMS, INC.
To: COMERICA BANK
Reel/Frame 045446/0307 →
RELEASE OF SECURITY INTEREST Recorded Oct 10, 2014
From: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
To: SEVENTH SENSE BIOSYSTEMS, INC.
Reel/Frame 033930/0464 →
SECURITY AGREEMENT Recorded Jan 27, 2014
From: SEVENTH SENSE BIOSYSTEMS, INC.
To: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
Reel/Frame 032126/0127 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2012
From: HAGHGOOIE, RAMIN; CHICKERING, DONALD E., III; DAVIS, SHAWN; MICHELMAN, MARK; BERNSTEIN, HOWARD; HORTON, KRISTIN
To: SEVENTH SENSE BIOSYSTEMS, INC.
Reel/Frame 028367/0625 →